GSK gets European marketing rights for Nucala to treat asthma – The Pharma Letter (registration)


The Pharma Letter (registration)

GSK gets European marketing rights for Nucala to treat asthma
The Pharma Letter (registration)
UK drug major GlaxoSmithKline (LSE: GSK) said the European Commission has granted marketing rights for its drug Nucala (mepolizumab) as an add-on treatment for asthma. Nucala is now approved for use in the 31 European countries covered by the …
EU OK for GSK's novel asthma biologicPharmaTimes
Nucala Now Available for Severe AsthmaMonthly Prescribing Reference (registration)
EU Grants Marketing Authorization to GSK's NucalaDrug Discovery & Development
StreetInsider.com –The FINANCIAL –RTT News
all 18 news articles »

View full post on asthma – Google News

Surrey couple claims human rights violated by smoking neighbour – The Province

Surrey couple claims human rights violated by smoking neighbour
The Province
A Surrey woman who says her neighbour's cigarette smoke wafts into her condo and triggers her asthma has won the right to launch a human rights complaint. Kathryn Arndt and her husband Douglas filed
Smoking neighbour human-rights case moves forward in BCMontreal Gazette

all 14 news articles »

View full post on asthma – Google News

Sandoz Negotiates Expanded RoW Rights to Vectura’s Asthma/COPD Drug VR315 – Genetic Engineering News


Stockopedia

Sandoz Negotiates Expanded RoW Rights to Vectura's Asthma/COPD Drug VR315
Genetic Engineering News
The Novartis generics business, Sandoz, negotiated expanded, rest-of-world (excluding the US) rights to Vectura's VR315 candidate combination therapy for asthma/COPD. Sandoz already holds European rights to the dry powder inhaler product.
Vectura Extends Novartis Deal For VR315 Lung DrugFox Business
VECTURA GROUP PLC : VR315 RoW License Agreement4-traders (press release)
Vectura signs up Sandoz for asthma drug in RoW; good results for ALK Abello The Pharma Letter
Stockopedia
all 9 news articles »

View full post on asthma – Google News

No ‘fish medicine’ for kids, says Andhra rights panel – iNewsOne


AFP

No 'fish medicine' for kids, says Andhra rights panel
iNewsOne
Hyderabad, May 31 (IANS) A fresh controversy hit the famous 'fish medicine' therapy for asthma patients as Andhra Pradesh Human Rights Commission Tuesday ordered that children below the age of 14 should not be administered it.
Indian kids eat live fish to cure asthmaStraits Times
Andhra Pradesh banned fish medicines for children to cure asthmaHealth(Y) Destination

all 24 news articles »

View full post on asthma – Google News

Rigel says Pfizer returns asthma therapy rights – Reuters

Rigel says Pfizer returns asthma therapy rights
Reuters
May 6 (Reuters) – Rigel Pharmaceuticals Inc said Pfizer Inc has returned the rights to Rigel's inhaled asthma therapy, following the world's biggest drugmaker's decision to exit research and development in the allergy and respiratory therapeutic area.
Rigel Assumes Development Responsibility for Inhaled Asthma TherapyPR Newswire (press release)
Pfizer Hands Back Rigel DrugXconomy

all 12 news articles »

View full post on asthma – Google News